Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: April 2011

Chapter 56 - Nutritional pharmacology

References

1. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31: 2316–23.
2. Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man's friend? Arch Intern Med 2003; 163: 317–23.
3. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683–93.
4. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008; 24: 215–22.
5. Gil KM, Forse RA, Askanazi J, et al. Energy metabolism in stress. London: John Libbey, 1985.
6. Uehara M, Plank LD, Hill GL. Components of energy expenditure in patients with severe sepsis and major trauma: a basis for clinical care. Crit Care Med 1999; 27: 1295–302.
7. Turner WW, Ireton CS, Hunt JL, Baxter CR. Predicting energy expenditures in burned patients. J Trauma 1985; 25: 11–16.
8. Zauner C, Schuster BI, Schneeweiss B. Similar metabolic responses to standardized total parenteral nutrition of septic and nonseptic critically ill patients. Am J Clin Nutr 2001; 74: 265–70.
9. Kreymann G, Grosser S, Buggisch P, et al. Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 1993; 21: 1012–19.
10. Monk DN, Plank LD, Franch-Arcas G, et al. Sequential changes in the metabolic response in critically injured patients during the first 25 days after blunt trauma. Ann Surg 1996; 223: 395–405.
11. Khorram-Sefat R, Behrendt W, Heiden A, Hettich R. Long-term measurements of energy expenditure in severe burn injury. World J Surg 1999; 23: 115–22.
12. Hersio K, Takala J, Kari A. et al. Patterns of energy expenditure in intensive-care patients. Nutrition 1993; 9: 127–32.
13. Brandi LS, Santini L, Bertolini R, et al. Energy expenditure and severity of injury and illness indices in multiple trauma patients. Crit Care Med 1999; 27: 2684–9.
14. Wolfe RR. Herman Award Lecture 1996: relation of metabolic studies to clinical nutrition-the example of burn injury. Am J Clin Nutr 1996; 64: 800–8.
15. Schricker T, Carli F, Lattermann R, Wachter U, Georgieff M. Glucose infusion does not suppress increased lipolysis after abdominal surgery. Nutrition 2001; 17: 85–90.
16. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978–82.
17. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300: 933–44.
18. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract 1996; 11: 151–6.
19. Schloerb PR, Henning JF. Patterns and problems of adult total parenteral nutrition use in US academic medical centers. Arch Surg 1998; 133: 7–12.
20. Singer P, Bursztein S, Kirvela O, et al. Hypercaloric glycerol in injured patients. Surgery 1992 ; 112: 509–14.
21. Carey GB. Mechanisms regulating adipocyte lipolysis. Adv Exp Med Biol 1998; 441: 157–70.
22. Doerrler W, Feingold KR, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994; 6: 478–84.
23. Miles JM. Lipid fuel metabolism in health and disease. Curr Opin Gen Surg 1993:78–84.
24. Goldstein SA, Elwyn DH. The effects of injury and sepsis on fuel utilization. Annu Rev Nutr 1989; 9: 445–73.
25. Sato N, Oyamatsu M, Tsukada K, et al. Serial changes in contribution of substrates to energy expenditure after transthoracic esophagectomy for cancer. Nutrition 1997; 13: 100–3.
26. Wood GC, Brown RO, Dickerson RN. Considerations in the use of lipid-based drug products. J Intraven Nurs 1998; 21: 45–9.
27. Lowrey TS, Dunlap AW, Brown RO, Dickerson RN, Kudsk KA. Pharmacologic influence on nutrition support therapy: use of propofol in a patient receiving combined enteral and parenteral nutrition support. Nutr Clin Pract 1996; 11: 147–9.
28. Mascioli EA, Lopes SM, Champagne C, Driscoll DF. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition 1996; 12: 245–9.
29. Stouthard JM, Endert E, Romijn JA, Sauerwein HP. Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr 1994; 18: 436–41.
30. Tissot S, Normand S, Khalfallah Y, et al. Effects of a continuous lipid infusion on glucose metabolism in critically ill patients. Am J Physiol 1995; 269: E753–8.
31. Druml W, Fischer M, Ratheiser K. Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. JPEN J Parenter Enteral Nutr 1998; 22: 217–23.
32. Nordenstrom J, Carpentier YA, Askanazi J, et al. Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 1982; 196: 221–31.
33. Battistella FD, Widergren JT, Anderson JT, et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 1997; 43: 52–8.
34. Waitzberg DL, Bellinati-Pires R, Salgado MM, et al. Effect of total parenteral nutrition with different lipid emulsions of human monocyte and neutrophil functions. Nutrition 1997; 13: 128–32.
35. Heller AR, Rossler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006; 34: 972–9.
36. Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006; 9: 140–8.
37. Wichmann MW, Thul P, Czarnetzki HD, et al. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007; 35: 700–6.
38. Mancuso P, Whelan J, DeMichele SJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 1997; 25: 523–32.
39. Planas M, Masclans JR, Iglesia R, et al. Eicosanoids and fat emulsions in acute respiratory distress syndrome patients. Nutrition 1997; 13: 202–5.
40. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27: 1409–20.
41. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34: 2325–33.
42. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34: 1033–8.
43. Pontes-Arruda A, DeMichele S, Seth A, Singer P. The use of an inflammation modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis evaluation of outcome data. JPEN J Parenter Enteral Nutr 2008; 32: 596–605.
44. Tashiro T, Yamamori H, Takagi K, Morishima Y, Nakajima N. Effect of severity of stress on whole-body protein kinetics in surgical patients receiving parenteral nutrition. Nutrition 1996; 12: 763–5.
45. Brown JA, Gore DC, Jahoor F. Catabolic hormones alone fail to reproduce the stress-induced efflux of amino acids. Arch Surg 1994; 129: 819–24.
46. Popovic PJ, Zeh HJ, Ochoa JB. Arginine and immunity. J Nutr 2007; 137: 1681S–1686S.
47. Wischmeyer PE. Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr Opin Clin Nutr Metab Care 2006; 9: 201–6.
48. Demling R. The use of anabolic agents in catabolic states. J Burns Wounds 2007; 6: e2.
49. Hart DW. Persistence of muscle catabolism after severe burn. Surgery 2000; 128: 312–19.
50. Jenkins RC, Ross RJ. Acquired growth hormone resistance in catabolic states. Baillieres Clin Endocrinol Metab 1996; 10: 411–19.
51. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Eng J Med 1999; 341: 785–92.
52. Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res 2006; 27: 131–9.
53. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Eng J Med 2001; 345: 1223–9.
54. Hall JC, Heel K, McCauley R. Glutamine. Br J Surg 1996; 83: 305–12.
55. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet 1990; 336: 523–5.
56. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001; 27: 84–90.
57. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30: 2022–9.
58. Preiser JC, Wernerman J. Glutamine, a life-saving nutrient, but why? Crit Care Med 2003; 31: 2555–6.
59. Wischmeyer PE. Glutamine and heat shock protein expression. Nutrition 2002; 18: 225–8.
60. Morrison AL, Dinges M, Singleton KD, et al. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006; 290: C1625–32.
61. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998; 83: 117–32.
62. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock 1999; 11: 1–12.
63. Ribeiro SP, Villar J, Downey GP, Edelson JD, Slutsky AS. Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protects rats against sepsis. Crit Care Med 1994; 22: 922–9.
64. Ribeiro SP, Villar J, Downey GP, Edelson JD, Slutsky AS. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: evidence for TNF-alpha posttranslational regulation. Am J Respir Crit Care Med 1996; 154: 1843–50.
65. Ribeiro SP, Villar J, Slutsky AS. Induction of the stress response to prevent organ injury. New Horiz 1995; 3: 301–11.
66. Moseley PL, Gapen C, Wallen ES, Walter ME, Peterson MW. Thermal stress induces epithelial permeability. Am J Physiol 1994; 267: C425–34.
67. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005; 33: 1206–13.
68. Singleton KD, Serkova N, Banerjee A, et al. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition 2005; 21: 214–23.
69. Singleton KD, Wischmeyer PE. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 2006; 25: 295–9.
70. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001; 90: 2403–10.
71. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001; 16: 398–402.
72. Wischmeyer PE, Riehm J, Singleton KD, et al. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 2003; 19: 1–6.
73. Wischmeyer PE, Vanden Hoek TL, Li C, et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr 2003; 27: 116–22.
74. Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005; 31: 1079–86.
75. Suchner U, Heyland DK, Peter K. Immune-modulatory actions of arginine in the critically ill. The Br J Nutr 2002; 1: S121–32.
76. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944–53.
77. Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation? Nutr Clin Pract 2004; 19: 216–25.
78. Berger MM, Chiolero RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007; 35: S584–90.
79. Baccaro F, Moreno JB, Borlenghi C, et al. Subjective global assessment in the clinical setting. JPEN J Parenter Enteral Nutr 2007; 31: 406–9.
80. Singh H, Watt K, Veitch R, Cantor M, Duerksen DR. Malnutrition is prevalent in hospitalized medical patients: are housestaff identifying the malnourished patient? Nutrition 2006; 22: 350–4.
81. Gatt M, MacFie J, McNaughton L, et al. Gut function is an independent indicator of patient outcome: proof of principle. Clin Nutr Suppl 2007; 2: 108.
82. Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr 2003; 27: 1–9.
83. Gianotti L, Braga M, Nespoli L, et al. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 1763–70.
84. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002; 137: 174–80.
85. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805–14.
86. Bozzetti F, Gavazzi C, Miceli R, et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr 2000; 24: 7–14.
87. Andersen HK, Lewis SJ, Thomas S. Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for postoperative complications. Cochrane Database Syst Rev 2006;. 4: CD004080.
88. Lewis SJ, Egger M, Sylvester PA, Thomas S. Early enteral feeding versus “nil by mouth” after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ 2001; 323: 773–6.
89. Neumayer LA, Smout RJ, Horn HG, Horn SD. Early and sufficient feeding reduces length of stay and charges in surgical patients. J Surg Res 2001; 95: 73–7.
90. Huang YC. Malnutrition in the critically ill. Nutrition 2001; 17: 745–6.
91. Bartlett RH, Dechert RE, Mault JR, et al. Measurement of metabolism in multiple organ failure. Surgery 1982; 92: 771–9.
92. Braga M, Gianotti L, Gentilini O, et al. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med 2001; 29: 242–8.
93. Archer SB, Burnett RJ, Fischer JE. Current uses and abuses of total parenteral nutrition. Adv Surg 1996; 29: 165–89.
94. Lipman TO. Bacterial translocation and enteral nutrition in humans: an outsider looks in. JPEN J Parenter Enteral Nutr 1995; 19: 156–65.
95. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991; 31: 629–36; discussion 36–8.
96. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002; 131: 241–4.
97. Suchner U, Senftleben U, Eckart T, et al. Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism. Nutrition 1996; 12: 13–22.
98. McClave SA, Lukan JK, Stefater JA, et al. Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med 2005; 33: 324–30.
99. DeJonghe B, Appere-De-Vechi C, Fournier M. et al. A prospective survey of nutritional support practices in intensive care unit patients: What is prescribed? What is delivered? Crit Care Med 2001; 29: 8–12.
100. Hurwitz M, Garcia MG, Poole RL, Kerner JA. Copper deficiency during parenteral nutrition: a report of four pediatric cases. Nutr Clin Pract 2004; 19: 305–8.
101. Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2002; 2: CD002920.
102. Griffith RD. Nutrition in intensive care: give enough but choose the route wisely? Nutrition 2001; 17: 53–5.
103. Jensen GL. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. JPEN J Parenter Enteral Nutr 2006; 30: 453–63.
104. Payne-James JJ, Silk DB. Hepatobiliary dysfunction associated with total parenteral nutrition. Dig Dis 1991; 9: 106–24.
105. Martinez Tutor MJ, Alfaro Olea A, Brea Corral JM, Castano Rodriguez AD. [Liver dysfunction associated with total parenteral nutrition]. Nutr Hosp 1993; 8: 22–9.
106. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121: e678–86.
107. MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr 2008; 32: 412–19.
108. Edes TE, Walk BE, Austin JL. Diarrhea in tube-fed patients: feeding formula not necessarily the cause. Am J Med 1990; 88: 91–3.
109. Medley F, Stechmiller J, Field A. Complications of enteral nutrition in hospitalized patients with artificial airways. Clin Nurs Res 1993; 2: 212–23.
110. Heimburger DC, Sockwell DG, Geels WJ. Diarrhea with enteral feeding: prospective reappraisal of putative causes. Nutrition 1994; 10: 392–6.
111. Taubes G. Collateral damage. The rise of resistant C. difficile. Science 2008; 321: 360.
112. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Eng J Med 2001; 345: 1359–67.
113. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Eng J Med 2006; 354: 449–61.
114. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Eng J Med 2008; 358: 125–39.
115. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283–97.
116. Frankenfield DC, Reynolds HN. Nutritional effect of continuous hemodiafiltration. Nutrition 1995; 11: 388–93.
117. Druml W. Protein metabolism in acute renal failure. Miner Electrolyte Metab 1998; 24: 47–54.
118. Fortin MC, Amyot SL, Geadah D, Leblanc M. Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy. Intensive Care Med 1999; 25: 594–8.